Synthesis and Antibacterial Activity of Oxazolidinone Derivatives Containing Nitro Heteroaromatic Moiety

被引：15

作者：

Xu Boxuan ^{[1
]}

Ding Xiudong ^{[2
]}

Wu Yachuang ^{[1
]}

Cui Lei ^{[2
]}

Qian Ping ^{[1
]}

Wang Di ^{[2
]}

Zhao Yanfang ^{[1
]}

机构：

[1] Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, Shenyang 110016, Liaoning, Peoples R China

[2] 309th Hosp PLA, Dept Clin Lab, Beijing 100091, Peoples R China

来源：

CHEMICAL RESEARCH IN CHINESE UNIVERSITIES | 2018年 / 34卷 / 01期

关键词：

Oxazolidinone derivative; Antibacterial activity; Linezolid; Ranbezolid; AGENTS; DISCOVERY; SAR;

D O I：

10.1007/s40242-018-7302-3

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

A series of novel oxazolidinone derivatives containing nitro heteroaromatic moiety was synthesized and characterized by means of H-1 NMR and MS spectra. All target compounds were evaluated for their in vitro antibacterial activities against S.au 29213, methicillin-resistant Staphylococcus aureus(MRSA) and vancomycin-resistant Enterococcus(VRE) by minimum inhibitory concentration(MIC) assay. Most of them exhibited antibacterial activity against S. au 29213, MRSA and VRE. Among them, compounds 10e and 10f displayed better activity than the control.

引用

页码：51 / 56

页数：6

共 19 条

[1]

Al-Shaar A. H., 1989, CHEMINFORM, V20, P551

[2] Antibiotic stewardship: overcoming implementation barriers [J].

Bal, Abhijit M. ;

Gould, Ian M. .

CURRENT OPINION IN INFECTIOUS DISEASES, 2011, 24 (04) :357-362

[3] Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America [J].

Boucher, Helen W. ;

Talbot, George H. ;

Bradley, John S. ;

Edwards, John E., Jr. ;

Gilbert, David ;

Rice, Louis B. ;

Scheld, Michael ;

Spellberg, Brad ;

Bartlett, John .

CLINICAL INFECTIOUS DISEASES, 2009, 48 (01) :1-12

[4] Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant Gram-positive bacterial infections [J].

Brickner, SJ ;

Hutchinson, DK ;

Barbachyn, MR ;

Manninen, PR ;

Ulanowicz, DA ;

Garmon, SA ;

Grega, KC ;

Hendges, SK ;

Toops, DS ;

Ford, CW ;

Zurenko, GE .

JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (03) :673-679

[5] Synthesis and SAR of novel oxazolidinones: Discovery of ranbezolid [J].

Das, B ;

Rudra, S ;

Yadav, A ;

Ray, A ;

Rao, AVSR ;

Srinivas, ASSV ;

Soni, A ;

Saini, S ;

Shukla, S ;

Pandya, M ;

Bhateja, P ;

Malhotra, S ;

Mathur, T ;

Arora, SK ;

Rattan, A ;

Mehta, A .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (19) :4261-4267

[6]

Dodda M. R., 2008, Novel Process for the Preparation of Linezolid and Related Compounds, Patent No. [US 20080021214, 20080021214]

[7] Antipneumococcal and antistaphylococcal activities of ranbezolid (RBX 7644), a new oxazolidinone, compared to those of other agents [J].

Hoellman, DB ;

Lin, GR ;

Ednie, LM ;

Rattan, A ;

Jacobs, MR ;

Appelbaum, PC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (03) :1148-1150

[8] Crystal structure of the oxazolidinone antibiotic linezolid bound to the 50S ribosomal subunit [J].

Ippolito, Joseph A. ;

Kanyo, Zoltan F. ;

Wang, Deping ;

Franceschi, Francois J. ;

Moore, Peter B. ;

Steitz, Thomas A. ;

Duffy, Erin M. .

JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (12) :3353-3356

[9] Design, synthesis, and SAR studies of mefloquine-based ligands as potential antituberculosis agents [J].

Jayaprakash, Sarva ;

Iso, Yasuyoshi ;

Wan, Baojie ;

Franzblau, Scott G. ;

Kozikowski, Alan P. .

CHEMMEDCHEM, 2006, 1 (06) :593-+

[10] Bacterial resistance: A worldwide problem [J].

Jones, RN ;

Pfaller, MA .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 31 (02) :379-388

← 1 2 →